Skip to main content

Table 1 Characteristics of the cohort

From: Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy

Variables   Included patients N = 129
Median (IQR)/N (%)
Age Years 72 (62–78)
Sex Females 48 (37.2)
BMI   25.3 (23.4–27.8)
CCI 5 (4–7)
ASA score 1 4 (3.1)
2 66 (51.2)
3 59 (45.7)
Type of surgery Anterior resection 94 (72.9)
Miles procedure 21 (16.3)
Hartmann procedure 14 (10.8)
Laparoscopy   63 (48.8)
Overall morbidity   43 (33.3)
Clavien-Dindo classification < 3 27 (20.9)
≥ 3 15 (11.6)
Redo surgery   8 (6.2)
Anastomotic leakagea   8/94 (8.5)
Tumor location High 64 (49.6)
Middle 41 (31.8)
Low 24 (18.6)
TNM stage I 30 (23.3)
II 33 (25.6)
III 41 (31.8)
IV 13 (10.1)
Positive resection margin   11 (8.5)
Adjuvant chemotherapy   61 (47.3)
  1. BMI body mass index, CCI Charlson comorbidity index, ASA American Society of Anesthesiologists
  2. aCalculated on the number of patients who underwent restorative surgery